ISRCTN36786212已完成不适用
(Added 14/08/09) Recombinant tissue plasminogen activator (rt-PA) and external ventricular drain (EVD) in subarachnoid haemorrhage (SAH) with obstructive hydrocephalus for lysis of ventricular blood. A randomised clinical trial.
niversity Medical Center Utrecht, Department of Neurology (The Netherlands)0 个研究点目标入组 16 人开始时间: 2006年1月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. First or recurrent aneurysmal subarachnoid haemorrhage with intraventricular extension of the haemorrhage
- •2. The ventricles must be enlarged and the intraventricular haemorrhage must be severe (Graeb-score more than 6)
- •3. Patients must be in a poor neurological condition, WFNS <7 or WFNS <6 in intubated patients
排除标准
- •1. Other cause for intraventricular haemorrhage than a subarachnoid haemorrhage from a ruptured intracranial aneurysm
- •2. Absence of both pupillary light reflexes
- •3. Use of oral anticoagulants
- •4. Treating physicians propose a palliative instead of curative treatment strategy
- •5. Absence of informed consent
研究者
相似试验
已完成
不适用
Recombinant tissue Plasminogen Activator administration by retinal branch vein route for Central Retinal Vein Occlusion: a randomised conventional therapy controlled trialCentral Retinal Vein Occlusion (CRVO)Eye DiseasesISRCTN58543190Oogziekenhuis Rotterdam (OZR) (The Netherlands)48
尚未招募
不适用
Tissue Plasminogen Activator levels in Diabetic footCTRI/2020/07/026277AIIMS Bhubaneswar
进行中（未招募）
1 期
The main goal of the study is to compare the safety and effectiveness of administering ADVATE using either continuous infusion or single, large dose infusions during and post surgery for patients requiring major orthopedic surgeryEUCTR2005-005697-71-SEBaxter Innovations GmbH21
进行中（未招募）
不适用
The main goal of the study is to compare the safety and effectiveness of administering ADVATE using either continuous infusion or single, large dose infusions during and post surgery for patients requiring major orthopedic surgeryEUCTR2005-005697-71-PLBaxalta Innovations GmbH21
进行中（未招募）
1 期
The main goal of the study is to compare the safety and effectiveness of administering ADVATE using either continuous infusion or single, large dose infusions during and post surgery for patients requiring major orthopedic surgerySubjects with Severe or Moderately Severe Hemophilia A (baselinefactor VIII (FVIII) level <= 2% of normal) hemophilia A undergoing major orthopedic surgeryMedDRA version: 17.0Level: LLTClassification code 10060612Term: Hemophilia ASystem Organ Class: 100000004850EUCTR2005-005697-71-BEBaxter Innovations GmbH72